海藻异枝麒麟菜多糖抑制尿石盐草酸钙晶体生长的研究

采用扫描电子显微镜(SEM)、 红外光谱(FTIR)和X射线衍射(XRD)方法研究了从海藻异枝麒麟菜中提取的硫酸多糖(ESPS)对草酸钙(CaOxa)晶体生长的影响. 结果表明, 添加ESPS能抑制一水草酸钙(COM)的生长, 同时诱导二水草酸钙(COD)晶体的形成. 随着ESPS的质量浓度从0增加到0.03和0.50 mg/mL, COD的质量分数从0分别增加到10%和55%; COM的(1 01)晶面加强, (020)晶面减弱直至消失, 并从三维晶体转变为棱角圆顿的四角形片状晶体; COM和COD的尺寸均明显变小. 这些结果表明, ESPS是抑制CaOxa结石形成的一种潜在药物.     

海藻硫酸多糖抑制草酸钙结石形成的化学模拟

用体外模拟方法研究了从海藻异枝麒麟菜中提取的硫酸多糖(ESPS)对尿结石患者尿液中草酸钙晶体生长的影响. ESPS不但诱导与尿路细胞膜粘附力较弱的二水草酸钙晶体形成, 而且抑制一水草酸钙的生长和聚集, 归因于一水草酸钙的富钙(101)晶面与聚阴离子ESPS之间的静电相互作用. 上述结果表明, ESPS是一种抑制草酸钙结石的潜在绿色药物.     

单分子膜诱导下尿大分子对草酸钙晶体物相和晶面的调控作用

采用SEM,XRD和FTIR手段比较研究了DPPC单分子膜诱导下尿大分子硫酸软骨素A(C₄S)、硫酸软骨素C(C₆S)和血清蛋白(SA)对尿石盐草酸钙晶体生长的影响.DPPC单分子膜不但优先选择一水草酸钙(COM)物相成核生长,而且优先选择COM的(101)晶面.没有添加剂时,得到的COM为三维的六棱柱和三维的菱形晶体;加入尿大分子抑制剂后,COM的(101)晶面进一步加强,其它晶面减弱,导致二维晶体的形成.COM的(101)晶面为富钙离子晶面,带有过剩的正电荷,而DPPC单分子膜头基带有负电荷,几种尿大分子在实验条件下亦带有负电荷,带负电荷的单分子膜及带负电荷的大分子共同作用于富钙离子的(101)晶面,使得COM的(101)晶面择优生长.C₄S,C₆S和SA的存在均能有效地抑制COM生长.     

大豆多糖对尿石矿物草酸钙形成的调控作用

采用水提法从大豆中提取了大豆多糖(SPS),其多糖百分含量为97.38%;平均相对分子质量为115,200,羧基百分含量为13.8%。采用X射线衍射法(XRD)、红外光谱(FTIR)、扫描电子显微镜(SEM)和电感耦合等离子体发射光谱仪(ICP)研究了水溶性大豆多糖(SPS)对草酸钙晶体生长的调控作用。SPS大豆多糖不但可以抑制一水草酸钙(COM)晶体的聚集,而且可以诱导二水草酸钙(COD)晶体形成。当SPS浓度由0增大到0.50g·L-1时,草酸钙晶体由COM完全转变为COD晶体;并且随着多糖浓度的增大,溶解在溶液中的钙离子(可溶性钙)浓度显著增加,草酸钙沉淀的物质的量逐渐减少。这些结果表明,SPS有望成为预防草酸钙结石的一种绿色药物。     

纳米、微米一水草酸钙和二水草酸钙对非离子表面活性剂NP-40的吸附差异

测定了不同浓度NP-40(c_NP-40)存在下各尺寸COM或COD晶体的吸附量;采用X射线衍射和红外光谱研究吸附前后晶体是否发生晶相改变;采用ζ电位仪测定吸附后晶体表面的ζ电位随c_NP-40的变化。结果表明:不同尺寸COM、COD对NP-40的吸附能力大小顺序为:50 nm > 100 nm > 1 μm >> 3 μm > 10 μm;相同尺寸的晶体,COM的吸附量大于COD。随着c_NP-40增加,3 μm和10 μm的COM、COD晶体的吸附曲线为S型,而50 nm、100 nm、1 μm的COM、COD晶体的吸附曲线为直线型。加入NP-40后,ζ电位绝对值与各晶体的吸附密度成正相关。提出了草酸钙晶体吸附NP-40的分子模型。晶体尺寸越小,对NP-40的吸附量越大。非离子表面活性剂虽然自身不带电荷,但吸附到COM、COD晶体表面后可以通过位阻斥力来增加晶体悬浮液的稳定性,有利于抑制草酸钙结石的形成。     

海藻多糖中硫酸基含量对抑制草酸钙晶体形成和修复受损伤肾小管上皮细胞的影响

采用X射线衍射法、傅里叶变换红外光谱仪、扫描电子显微镜、ζ电位仪和电感耦合等离子体发射光谱仪,比较了4种分子量相近(约3 700 Da)、但硫酸基(—OSO₃^-)含量不同的降解海藻多糖对草酸钙(CaC₂O₄)晶体生长的调控作用;采用细胞实验比较了它们对受损伤肾小管上皮细胞(HK-2)的修复能力。这4种海藻多糖分别是降解紫菜多糖(PY-1)、降解龙须菜多糖(GL-2)、降解羊栖菜多糖(SF-3)和降解裙带菜多糖(UP-4),其—OSO₃^-含量分别为17.9%、13.3%、8.2%和5.5%。结果表明,这4种多糖均能够抑制一水草酸钙(COM)生长,诱导二水草酸钙(COD)生成,增加溶液中可溶性Ca²⁺离子浓度,增加晶体表面的ζ电位绝对值,从而降低晶体的聚集程度;这些多糖均能修复被草酸氧化损伤的HK-2细胞,提高细胞活力和超氧化物歧化酶(SOD)活力,降低丙二醛(MDA)的释放量。结果表明,多糖中—OSO₃^-...     

邻苯二酚做螯合剂合成不同粒度、形貌的全硅方钠石分子筛大单晶

将邻苯二酚作为螯合剂加入到合成全硅方钠石分子筛的体系 (SiO2-NaOH -EG -R(R :邻苯二酚 ) )中 ,合成了 15 μm× 15 μm× 15 μm～ 6 0 μm×6 0 μm× 6 0 μm粒度不等的高质量的Si-SOD分子筛单晶 .实验结果表明 :当体系中有邻苯二酚存在时得到的产物具有较大尺寸和完美形貌的单晶 ,而不加邻苯二酚时却得到尺寸很小的孪晶 ;同时 ,体系中邻苯二酚的含量对晶体的粒度也有很大影响 .晶化动力学表明 ,邻苯二酚的加入极大地降低了晶化速度 ,这可能与体系中形成了硅 -邻苯二酚螯合物有关     

不同尺寸六边形一水草酸钙晶体的合成、表征、性质及其细胞毒性

通过改变反应温度、溶剂、添加剂和搅拌速度,合成了尺寸分别为(1.5±0.4)、(3.5±0.5)、(5.5±0.5)和(9.5±1)μm的4种一水草酸钙(COM)晶体,比较了它们的理化性质差异。加入添加剂Na3Cit,增加搅拌速度,降低反应温度或降低溶剂的介电常数,均有利于获得小尺寸的晶体。X射线衍射(XRD)和傅立叶变换红外光谱(FT-IR)检测表明,这些晶体均为单相的COM晶体;扫描电子显微镜(SEM)观察显示,随着晶体尺寸由1μm增大到9μm,晶体由表面粗糙的圆钝形演变为表面光滑的薄片状,其高电荷密度的(101)晶面增大,晶体表面电荷密度增加,ζ电位绝对值也增大,形成的悬浮液稳定性越高。这些COM晶体对人肾近曲小管上皮细胞(HK-2)的损伤能力与其尺寸成负相关。     

硅凝胶体系中不同结构羧酸钾对草酸钙结晶的影响

采用扫描电子显微镜(SEM)和X射线衍射(XRD)方法研究了硅凝胶体系中不同种类羧酸钾对草酸钙(CaC₂O₄)晶体生长的调控作用. 加入一元醋酸钾(KOAc)只生成一水草酸钙(COM)晶体; 三元柠檬酸钾(K₃Cit)和四元乙二胺四乙酸二钾(K₂EDTA)可诱导二水草酸钙(COD)形成, 且随着其浓度增加, 对COD的诱导能力增加, 而二元酒石酸钾(K₂Tart)同时诱导了COM, COD和三水草酸钙(COT)生成. 随着结晶温度降低, 多元酸钾可以进一步减小COM晶体的比表面积, 增加COD的百分含量, 但K₂Tart诱导COT的能力减弱. 由于诱导COD和COT晶体形成、减小COM的比表面积均有利于防止草酸钙尿石的形成, 因此, 多元羧酸钾可用于草酸钙结石的预防和治疗.     

土家族药物天葵化石汤提取液抑制草酸钙结石形成的化学模拟

采用扫描电子显微镜(SEM)和X射线衍射法(XRD)研究了土家族药物天葵化石汤(Tiankui)的提取液对尿石晶体草酸钙(CaOxa)成核、生长的抑制作用及其对二水草酸钙(COD)的稳定作用. 当Tiankui浓度小于30 mg/mL时, 主要生成一水草酸钙(COM), 但可使COM晶体棱角圆钝. 随着Tiankui浓度增加至45和75 mg/mL, 可分别诱导95%和100%的COD晶体生成. Tiankui还可以稳定COD在水溶液中的存在, 没有Tiankui存在时, COD在48 h内全部转化为COM晶体, 而在12 mg/mL Tiankui存在下, COD仅有20%转化. 从Tiankui提取液的活性组分、与草酸钙不同晶相间的吸附差异、化学配位等角度讨论了其抑制CaOxa生长和诱导稳定COD的化学基础.     

粘液素对草酸钙晶体生长的影响

泌尿系结石是一种常见疾病。在70％以上的结石中,草酸钙(CaOxa)单独或和其它钙盐共同为主要成分。一般认为正常人不形成尿石是其尿液中存在的抑制剂抑制了CaOxa晶体的成核、生长、聚集或固相转化。     

Simulation of calcium oxalate stone in vitro

Urolithiasis constitutes a serious health problem that affects a significant section of mankind. Between 3% and 14% of the population, depending on the geographical region, suffer from this illness[1]. For example, the incidence of urolithiasis in Florida in the United States of America was 15.7 in 100000 people and increased to 20.8 in 1996. Urolithiasis remains a major medical prob-lem in China, especially in Guangdong Province. A survey in 1997 in Shenzhen City, the most southern city i…     

Mimicking the biomolecular control of calcium oxalate monohydrate crystal growth: effect of contiguous glutamic acids

Scanning confocal interference microscopy (SCIM) and molecular dynamics (MD) simulations were used to investigate the adsorption of the synthetic polypeptide poly(l-glutamic acid) (poly-glu) to calcium oxalate monohydrate (COM) crystals and its effect on COM formation. At low concentrations (1 μg/mL), poly-glu inhibits growth most effectively in ?001? directions, indicating strong interactions of the polypeptide with {121} crystal faces. Growth in ?010? directions was inhibited only marginally by 1 μg/mL poly-glu, while growth in ?100? directions did not appear to be affected. This suggests that, at low concentrations, poly-glu inhibits lattice-ion addition to the faces of COM in the order {121} > {010} ≥ {100}. At high concentrations (6 μg/mL), poly-glu resulted in the formation of dumbbell-shaped crystals featuring concave troughs on the {100} faces. The effects on crystal growth indicate that, at high concentrations, poly-glu interacts with the faces of COM in the order {100} > {121} > {010}. This mirrors MD simulations, which predicted that poly-glu will adsorb to a {100} terrace plane (most calcium-rich) in preference to a {121} (oblique) riser plane but will adsorb to {121} riser plane in preference to an {010} terrace plane (least calcium-rich). The effects of different poly-glu concentration on COM growth (1-6 μg/mL) may be due to variations between the faces in terms of growth mechanism and/or (nano)roughness, which can affect surface energy. In addition, 1 μg/mL might not be adequate to reach the critical concentration for poly-glu to significantly pin step movement on {100} and {010} faces. Understanding the mechanisms involved in these processes is essential for the development of agents to reduce recurrence of kidney stone disease.     

Inhibition of the Crystal Growth and Aggregation of Calcium Oxalate by Algae Sulfated Polysaccharide In-vitro

Kidney stone disease causes substantial suffering and occasional renal failure. The content of calcium oxalate (CaOxa) is up to 70-80% in the stones1,2. However, the mechanism of the formation of urinary stones is not yet clearly understood and the questi…     

Effects of amino acids on crystal growth of CaC2O4 in reverse microemulsion

Crystal growth of calcium oxalate (CaC2O4) in bulk aqueous solution, reverse microemulsion of p-octyl polyethylene glycol phenylether (OP)/iso-octyl alcohol (IOA)/cydohexane/water and above microemulsions containing different kinds of amino acids, such as aspartic acid (Asp), tyrosine (Tyr) and tryptophan (Trp) were studied. The results indicated that different crystallization types of the crystals, which were calcium oxalate monohydrate (COM), calcium oxalate dihydrate (COD) and calcium oxalate trihydrate (COT), existed in bulk aqueous solution. But CaC2O4 growth mainly paralleled with (1 01) plane of COM in reverse microemulsion because of the induction of surfactant at water/oil interface. After adding amino acids into microemulsions, the growth of CaC2O4 crystals mainly influenced by the varieties of amino acids and the pH values of the amino acid aqueous solution. When pH values of the solutions was higher than isoelectric points of amino acids, CaC2O4 crystal paralleled with (1 01) plane of COM more easily with the addition of Trp, Tyr, Asp in turn; however, when pH of the solutions was lower than isoelectric points of Trp, CaC2O4 crystal growth paralleled with (020) face of COM. It is obviously that amino acids, pH values of the solutions and surfactant played important roles in the process of crystal growth of CaC2O4 in the microemulsions. The formation mechanism of CaC2O4 was also discussed in different microemulsions at last.     

沙苑子提取液对不同体系中草酸钙晶体生长影响的研究

通过与水、氯化钠、正常人尿液体系的比较,重点研究了结石患者尿液体系中加入中药沙苑子提取液对草酸钙晶体生长的的影响,利用SEM,FTIR和XRD等测试手段对所得晶体进行表征。结果发现:在结石患者尿液体系中形成的草酸钙晶体为一水草酸钙(COM)晶体,而在这4种体系中加入沙苑子提取液后,只形成二水草酸钙(COD)晶体,表明沙苑子提取液能抑制COM晶体生长,并且随着沙苑子提取液浓度增大,抑制作用增强。沙苑子抑制草酸钙晶体生长的可能机理进行了探讨。